FDA Expects Draft Document On Post-Approval Study Design By September
This article was originally published in The Gray Sheet
Executive Summary
FDA hopes to complete a draft scientific document on how to design post-approval studies for medical devices by September, according to Danica Marinac-Dabic, director of the Division of Epidemiology within CDRH's Office of Surveillance and Biometrics